FLT3 and myelodysplastic syndrome: Among the various HSPC subpopulations, only HSC (c-Kit+/LineageNegative/Sca-1+/CD34-/Flk-2-) were significantly decreased in MDS, but not AML, mice compared to control (Fig 4E, p<0.05).